Éric Letouzé

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

50h-index12.9kcitations204works9.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(51), Hepatitis B Virus Studies(44), Cancer Genomics and Diagnostics(33), Cancer, Hypoxia, and Metabolism(31), Adrenal and Paraganglionic Tumors(28)

Publications203 total

Mycosis fungoides with nodal progression harbors recurrent SOCS1 mutations and JAK2 rearrangements
European Journal of Cancer·2025
130MO Single-cell molecular profiling of metastatic urothelial carcinoma under immune checkpoint blockade
ESMO Open·2025Open Access
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer
EMBO Molecular Medicine·2025· 2 citedOpen Access
Abstract 738: Single-cell trajectories of metastatic urothelial cancer and individual patterns of resistance to immune checkpoint inhibitors
Cancer Research·2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
New England Journal of Medicine·2025· 35 cited
CRCI<sup>2</sup>NA inaugural symposium: A meeting on tumor and immune ecosystems
Biology of the Cell·2024· 1 citedOpen Access
BCMA Extracellular Domain Functional Hotspots and Resistance to Variable Anti-BCMA T Cell Engagers in Multiple Myeloma
Blood·2024· 1 cited
Primary cilia promote EMT-induced triple-negative breast tumor heterogeneity and resistance to therapy
2024
Role and timing of chromosome deletions in multiple myeloma
Blood·2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma
Nature Communications·2024· 32 citedOpen Access
Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications
Blood Advances·2024· 33 citedOpen Access
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Nature Communications·2023· 12 citedOpen Access
Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation
Nature Cancer·2023· 3 citedOpen Access
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation
Nature Cancer·2023· 61 citedOpen Access
S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA
HemaSphere·2023Open Access
Acquired resistance to bispecific antibodies by genetic or epigenetic inactivation of the target in multiple myeloma
2023Open Access
Supplementary Tables from Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
2023Open Access
Data from Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
2023Open Access
Supplementary Tables from Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
2023Open Access
Supplementary Figures from Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Jessica Zucman‐Rossi(23), Sandrine Imbeaud(20), Julien Caldéraro(15), Paulette Bioulac‐Sage(14), Jean‐Charles Nault(13), Jean‐Frédéric Blanc(12), Gabrielle Couchy(11), Anne‐Paule Gimenez‐Roqueplo(11), Judith Favier(11), Alexis Laurent(10), Sandra Rebouissou(9), Quentin Bayard(9), Jérôme Bertherat(8), Stefano Caruso(8), Aurélien de Reyniès(7), Théo Z. Hirsch(7), Charles Balabaud(6), Giuliana Amaddeo(6), Laurence Amar(6), Nabila Elarouci(6)